Culture Biosciences specializes in cloud-connected bioreactor technology that enhances bioprocess development for various applications, including protein therapeutics, viral vectors, and synthetic biology. Their bioreactors, which include a 250mL bench-scale single-use model and a 5L single-use model, are designed to facilitate flexible and scalable experimentation. The company offers a "Culture as a Service" model, allowing clients to run experiments and analyze data in real-time through their proprietary software, Console™. This cloud-based platform enables users to design experiments, monitor processes, and derive insights efficiently, thereby accelerating the development cycle and reducing bottlenecks in bioprocessing.

The modular nature of Culture Biosciences' bioreactors allows for easy scaling to meet varying experimental needs, making it suitable for both small-scale and larger-scale applications. Their approach emphasizes remote collaboration and real-time data access, which empowers teams to work together seamlessly, regardless of location. Additionally, the integration of data science and in silico modeling supports the design of experiments, further enhancing the capabilities of researchers in optimizing their bioprocesses without the need for extensive internal infrastructure investment.

United States

Culture is your bioreactor lab, in the cloud.

We help scientists accelerate bioprocess development with our high-throughput bioreactor cloud lab. You design your experiment, and we execute the experiment in our lab using our 250mL bioreactors. We take care of the high-quality execution so that you can focus on developing processes. 

While your experiment runs in our lab, you can monitor and analyze your data in real time using our online dashboard. With Culture, get faster insights to make better, data-driven decisions.

Culture Biosciences

Company Details